Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Combination therapy with vigabatrin and prednisolone
(D00535)		[1] Vigabatrin[1] Vigabatrin (D00535) 💬 [1] ABAT 💬 [6] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 145 💬
2Cosyntropin injectable suspension 1 MG/ML + vigabatrin
(D00535)		[2] Tetracosactide,
Vigabatrin		[3] Cosyntropin ,
Vigabatrin (D00535),
Tetracosactide acetate 💬 		[2] ABAT,
MC2R 💬 		[12] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Hormone signaling, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬[1] 145 💬
3Vigabatrin
(D00535)		[1] Vigabatrin[1] Vigabatrin (D00535) 💬 [1] ABAT 💬 [6] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[2] 145, 158 💬
4Vigabatrin tablets
(D00535)		[1] Vigabatrin[1] Vigabatrin (D00535) 💬 [1] ABAT 💬 [6] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 145 💬